Understanding the GLP-1 consumer The GLP-1 era has given rise to multiple distinct consumer types, each with shared, yet nuanced, nutritional needs: Consumers currently using GLP-1 therapies face unique challenges, including appetite suppression that can make meeting nutritional requirements difficult, potential gastrointestinal side effects and concerns about maintaining muscle mass during weight loss
Do not purchase or inject products marketed as Retatrutide from unknown clinics, research suppliers, social-media sellers, or unverified websites
Tirzepatide for managing overweight and obesity TA1026
The advancement of economical manufacturing procedures and biosimilars is an urgent need
I had some onion rings and started on the salad and realized I could not eat any more of this. KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFFan independent source of health policy research, polling, and journalism
Those results, showing 28.7% weight loss at the 12mg dose, have generated enormous excitement and set a high bar for what TRIUMPH-1 might confirm in a broader obesity population